National Institutes of Health Funds Advanced Clinical Trials for Next-Generation mRNA Vaccines Targeting Emerging Pathogens
The National Institutes of Health awarded fifty million United States dollars in competitive research grants to university medical centers to accelerate human clinical trials for versatile mRNA vaccines designed to combat emerging viral threats.